TransMedics Group, Inc.
TMDX
$122.75
$0.6350.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.68M | 6.86M | 4.22M | 12.19M | 12.20M |
| Total Depreciation and Amortization | 6.14M | 5.68M | 5.18M | 4.60M | 4.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.73M | 12.96M | 8.71M | 8.75M | 8.16M |
| Change in Net Operating Assets | -44.40M | -5.83M | -11.25M | 177.00K | -28.10M |
| Cash from Operations | -2.86M | 19.66M | 6.86M | 25.72M | -3.44M |
| Capital Expenditure | -27.04M | -13.61M | -48.20M | -23.76M | -44.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 441.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -27.04M | -13.61M | -47.76M | -23.76M | -44.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.03M | 1.19M | 7.86M | 10.64M | 3.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.03M | 1.19M | 7.86M | 10.64M | 3.19M |
| Foreign Exchange rate Adjustments | 358.00K | -687.00K | 386.00K | -62.00K | -173.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.51M | 6.56M | -32.66M | 12.53M | -44.60M |